Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.
This report contains market size and forecasts of Meningococcal Vaccine in global, including the following market information:
Global Meningococcal Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Meningococcal Vaccine Market Sales, 2017-2022, 2023-2028, (10K Pcs)
Global top five Meningococcal Vaccine companies in 2021 (%)
The global Meningococcal Vaccine market was valued at 269.6 million in 2021 and is projected to reach US$ 359.8 million by 2028, at a CAGR of 4.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Meningtits A Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Meningococcal Vaccine include Novartis, GSK, Merck, CSL, Baxter, JN International Medical Corporation, Serum Institute of India, Bio-Med and China National Biotec Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Meningococcal Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Meningococcal Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (10K Pcs)
Global Meningococcal Vaccine Market Segment Percentages, by Type, 2021 (%)
Meningtits A
Polysaccharide Meningtitis AC
Meningitis ACYW
Global Meningococcal Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (10K Pcs)
Global Meningococcal Vaccine Market Segment Percentages, by Application, 2021 (%)
6 Months-15Year
over 3 Year
over 2 Year
over 3 Months
Global Meningococcal Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (10K Pcs)
Global Meningococcal Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Meningococcal Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Meningococcal Vaccine revenues share in global market, 2021 (%)
Key companies Meningococcal Vaccine sales in global market, 2017-2022 (Estimated), (10K Pcs)
Key companies Meningococcal Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
GSK
Merck
CSL
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
China National Biotec Group
Hualan Bio
Walvax
Zhifei